changing the standard of care in previously treated metastatic renal cell carcinoma
Published 8 years ago • 146 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
2:31
changing the standard of care in previously treated metastatic renal cell carcinoma
-
3:26
nivolumab and cabozantinib versus standard of care in renal cell carcinoma
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
6:53
goals in previously treated advanced renal cell carcinoma
-
1:42
current treatment landscape in renal cell carcinoma
-
0:55
the emerging continuum of care in metastatic kidney cancer in the second-line and beyond
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
1:02
an expert looks to the future of metastatic kidney cancer treatment
-
9:52
phase 3 axitinib data in patients with previously treated advanced renal cell carcinoma
-
3:59
the future of renal cell carcinoma
-
5:36
sequencing metastatic renal cell carcinoma treatments
-
3:36
first-line treatment of poor-risk metastatic renal cell carcinoma
-
3:23
nivolumab improves overall survival for advanced kidney cancer
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
5:11
current treatment landscape for kidney cancer
-
6:53
treatment of metastatic non-clear cell renal cell carcinoma
-
6:23
second-line treatment of metastatic renal cell carcinoma
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma